Gurnee, IL, United States of America

Edward Anthony Pec

This inventor holds 2 USPTO granted patents. Top assignee: Abbott Laboratories Corporation. Active years: 2000-2002.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • Brookfield, IL (US) (2000)
  • Gurnee, IL (US) (2002)

Company Filing History:


Years Active: 2000-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Edward Anthony Pec: Innovator in Pharmaceutical Formulations

Introduction

Edward Anthony Pec is a notable inventor based in Gurnee, IL (US). He has made significant contributions to the field of pharmaceutical formulations, holding a total of 2 patents. His work focuses on creating stable formulations that enhance the efficacy of therapeutic agents.

Latest Patents

Edward's latest patents include innovative cosolvent formulations. These formulations consist of a therapeutic agent, a low molecular weight alcohol, and a glycol derivative. The preferred formulations feature 19-nor-1α,3β,25-trihydroxy-9,10-secoergosta-5,7(E),22(E)-triene. This work aims to improve the stability and effectiveness of pharmaceutical products.

Career Highlights

Edward Anthony Pec is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His role at Abbott has allowed him to contribute to advancements in pharmaceutical science, particularly in the development of stable formulations.

Collaborations

Some of Edward's coworkers include Kathee Jantzi and Dennis A Stephens. Their collaborative efforts have likely played a role in the success of the projects they have worked on together.

Conclusion

Edward Anthony Pec's contributions to pharmaceutical formulations demonstrate his commitment to innovation in the healthcare industry. His patents reflect a dedication to improving therapeutic agents, which can lead to better patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…